HighTower Advisors
ACLX

HighTower Advisors’s Arcellx ACLX Stock Holding History

HighTower Advisors’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,558
Closed -$819K – 3800
2025
Q4 		$819K Sell
12,558
-2
-0% -$160 ﹤0.01% 2272
2025
Q3 		$1.03M Buy
12,560
+18
+0.1% +$1.3K ﹤0.01% 2069
2025
Q2 		$826K Sell
12,542
-134
-1% -$8.34K ﹤0.01% 2140
2025
Q1 		$832K Buy
12,676
+94
+0.7% +$6.37K ﹤0.01% 2080
2024
Q4 		$965K Buy
12,582
+97
+0.8% +$8.38K ﹤0.01% 1987
2024
Q3 		$1.04M Buy
12,485
+40
+0.3% +$2.66K ﹤0.01% 1914
2024
Q2 		$687K Buy
12,445
+5
+0% +$272 ﹤0.01% 2094
2024
Q1 		$864K Sell
12,440
-7
-0.1% -$444 ﹤0.01% 1892
2023
Q4 		$691K Buy
12,447
+39
+0.3% +$1.76K ﹤0.01% 2072
2023
Q3 		$445K Buy
12,408
+118
+1% +$4.07K ﹤0.01% 2312
2023
Q2 		$388K Buy
12,290
+64
+0.5% +$2.45K ﹤0.01% 2368
2023
Q1 		$376K Buy
12,226
+654
+6% +$19.8K ﹤0.01% 2295
2022
Q4 		$359K Buy
11,572
+72
+0.6% +$1.65K ﹤0.01% 2347
2022
Q3 		$216K Buy
11,500
+1,500
+15% +$28.7K ﹤0.01% 2553
2022
Q2 		$181K Buy
+10,000
New +$129K ﹤0.01% 2659

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

HighTower Advisors's ACLX Position: Q1 2026 in Review

HighTower Advisors sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 12,558 shares — an estimated $819K sold.

HighTower Advisors first reported a position in ACLX in Q2 2022 and held it in 15 quarters. The position peaked at $1.04M in Q3 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • HighTower Advisors reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 12,558 Arcellx shares in Q1 2026, an estimated $819K.
  • HighTower Advisors first reported a position in Arcellx in Q2 2022 and held it in 15 quarters.
  • HighTower Advisors's Arcellx position peaked at $1.04M in Q3 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.